The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-κB pathway

Journal of Cellular Physiology

Volumn 208, Issue 1, 2006, Pages 154-160

  Miranda, Claudia ^a   Roccato, Emanuela ^a   Raho, Giovanna ^a   Pagliardini, Sonia ^a   Pierotti, Marco A ^a,b   Greco, Angela ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TANK; PROTEIN TFG; PROTEIN TYROSINE KINASE A; TRK FUSED GENE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FUSION; GENE REARRANGEMENT; GENETIC SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN MOTIF; TWO HYBRID SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, GEL; HELA CELLS; HUMANS; I-KAPPA B KINASE; IMMUNOPRECIPITATION; NF-KAPPA B; PROTEIN INTERACTION MAPPING; PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33744904714     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20644     Document Type: Article

References (32)

1. Agou F, Traincard F, Vinolo E, Courtois G, Yamaoka S, Israel A, Veron M. 2004. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem 279:27861-27869.
2. Brummelkamp TE, Nijman SM, Dirac AM, Bernards E. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801.
3. Chariot A, Leonardi A, Muller J, Bonif M, Brown K, Siebenlist U. 2002. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 277:37029-37036.
4. Cheng G, Baltimore D. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev 10:963-973.
5. Chung JY, Park YC, Ye H, Wu H. 2002. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115:679-688.
6. Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F, Verma IM. 2004. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 304:1963-1967.
7. Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl: S81-S96):S81-S96.
8. Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA. 1995. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol 15:6118-6127.
9. Greco A, Fusetti L, Miranda C, Villa E, Zanotti S, Pagliardini S, Pierotti MA. 1998. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TEK-T3 oncogene. Oncogene 16:809-816.
10. Hernandez L, Pinyol M, Hernandez S, Bea S, Pulford K, Rosenwald A, Lamant L, Falini B, Ott G, Mason DY, Delsol DY, Campo E. 1999. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood 94:3265-3268.
11. Hisaoka M, Ishida T, Imamura T, Hashimoto H. 2004. TFG is a novel fusion partner of NORI in extraskeletal myxoid chondrosarcoma. Genes Chrom Cancer 40:325-328.
12. Ito T, Matsui Y, Ago T, Ota K, Sumimoto H. 2001. Novel modular domain PB1 recognizes PC motif to mediate functional protein-protein interactions. EMBO J 20:3938-3946.
13. Karin M. 1999. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 18:6867-6874.
14. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. 2003. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424:801-805.
15. Lupas A. 1996. Coiled-coils: New structures and new functions. Trends Biochem Sci 21:375-382.
16. Makris C, Roberts JL, Karin M. 2002. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation. Mol Cell Biol 22:6573-6581.
17. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S. 2003. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22:3307-3318.
18. Mencinger M, Aman P. 1999. Characterization of TFG in mus musculus and Caenorhabditis elegans. Biochem Biophys Res Commun 257:67-73.
19. Mencinger M, Panagopoulos I, Andreasson P, Lassen C, Mitelman F, Aman P. 1997. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma. Genomics 41:372-331.
20. Nakata T, Kitamura Y, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K, Emi M. 1999. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 25:97-103.
21. Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, Chiappetta G, Terrazzano G, Liguoro D, Vito P, Consiglio E, Formisano S, Leonardi A. 2004. Oncogenic and anti-apoptotic activity of NF-{kappa}B in human thyroid carcinomas. J Biol Chem 279:54610-54619.
22. Pomerantz JL, Baltimore D. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694-6704.
23. Roccato E, Pagliardini S, Cleris L, Canevari S, Formelli F, Pierotti MA, Greco A. 2003. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation. Oncogene 22:807-818.
24. Roccato E, Miranda C, Raho G, Pagliardini S, Pierotti MA, Greco A. 2005. Analysis of SHP-1 mediated downregulation of the TRK-T3 oncoprotein identifies TFG as a novel SHP-1 interacting protein. J Biol Chem 280:3382-3389.
25. Rothe M, Xiong J, Shu HB, Williamson K, Goddard A, Goeddel DV. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA 93:8241-8246.
26. Rothwarf DM, Zandi E, Natoli G, Karin M. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395:297-300.
27. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW. 2000. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev 14:854-862.
28. Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, Casanova JL, Israel A. 2002. The NF-kappaB signalling pathway in human diseases: From incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11:2371-2375.
29. Stilo R, Liguoro D, Di Jeso B, Formisano S, Consiglio E, Leonardi A, Vito P. 2004. Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator. J Biol Chem 279:34323-34331.
30. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14:289-301.
31. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793-796.
32. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93:1231-1240.